Novo Nordisk A/S v. Caraco Pharmaceutical Laboratories, Ltd., 601 F.3d 1359 (Fed. Cir. 2010) (RADER; CLEVENGER,, concurring; DYK, dissenting) NovoNordisk04142010

MAJOR ISSUES:  listing method-of-use claims with Food and Drug Administration; FDA approved uses; labeling of generic drugs; Hatch-Waxman Act; 2003 counterclaim amendment Read CPLRG™ 0050

Suitco Surface, Inc., In re, 603 F.3d 1255 (Fed. Cir. 2010) (RADER, Prost & Moore)SuitcoSurface04142010

MAJOR ISSUES: PTO reexamination; broadest reasonable construction of claims; construction not reasonable; PTO findings on reference disclosure Read CPLRG™ 0049

Anascape, Ltd. v. Nintendo of America, Inc., 601 F.3d 1333 (Fed. Cir. 2010) (NEWMAN & Dyk; GAJARSA, concurring)Anascape04132010

MAJOR ISSUES: written description; new matter; continuation-in-part application redesignated as continuation Read CPLRG™ 0048

MBO Laboratories, Inc. v. Becton, Dickinson & Co., 602 F.3d 1306, 2010 U.S. App. LEXIS 7424 (Fed. Cir. 2010) (GAJARSA, Clevenger & Dyk)MBOLaboratories04122010

MAJOR ISSUES:  reissue patent recapture rule; original claims not invalid; arguments and amendments in related applications Read CPLRG™ 0047

SiRF Technology, Inc. v. U.S. Int’l Trade Comm’n, 601 F.3d 1319, 2010 U.S. App. LEXIS 7423 (Fed. Cir. 2010) (DYK, Michel & Clevenger)SiRFTechnology04122010

MAJOR ISSUES: patent eligible processes under Section 101; Bilski; standing to sue; inventor’s prior assignment; invention assignment agreements as automatic transfer of future inventions; recording assignment with PTO; burden of proof; joint infringement; control and direction requirements; method claims requiring action only by a single party Read CPLRG™ 0046